Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2020, vol. 29, nr 4, April, p. 469–473

doi: 10.17219/acem/115237

Publication type: original article

Language: English

License: Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Social participation of patients with multiple sclerosis

Anna Pokryszko-Dragan1,A,B,C,D,E,F, Karol Marschollek2,B,C,F, Aleksandra Chojko2,B,C,F, Magdalena Karasek2,B,C,F, Adam Kardyś2,B,C,F, Paweł Marschollek2,B,C,F, Ewa Gruszka1,B,C,F, Marta Nowakowska-Kotas1,B,C,D,F, Sławomir Budrewicz1,A,E,F

1 Clinical Department of Neurology, Wroclaw Medical University, Poland

2 Students’ Scientific Club, Department of Neurology, Wroclaw Medical University, Poland

Abstract

Background. The effect multiple sclerosis (MS) has on the social functioning and integration of patients has been recently considered as an important factor of the disease.
Objectives. To assess social participation of MS patients with regard to demographic and disease-related variables.
Material and Methods. The study comprised 201 MS patients: 140 women, 61 men, aged 24–69 years. The World Health Organization Disability Assessment Schedule (WHODAS 2.0) was applied to assess the aspects of social functioning and the Beck Depression Inventory (BDI) was applied to evaluate the level of depression. Disease duration, degree of disability in Expanded Disability Status Scale (EDSS), most disabling symptoms and type of treatment were determined. WHODAS 2.0 scores (total and within particular domains) and their relationships with age, gender, disease-related variables and level of depression were analyzed.
Results. The results of WHODAS 2.0 for 27.4% of patients exceeded the 90th percentile compared to the population norms (with the highest scores for “getting around” and “participation in society” domains). The results of BDI and WHODAS 2.0 were strongly correlated (p < 0.001; β = 0.73) and mobility impairment was related to both of them (p < 0.001; β = –0.12 and 0.25, respectively). Other disabling symptoms were associated with scores in domains “understanding and communicating”, “getting around” and “participation in society”.
Conclusion. Social participation of the MS patients is affected by the impact of disease and associated with depression. Particular symptoms of neurological deficit (motor and visual impairment, fatigue) influence social functioning more than general disease-related variables.

Key words

depression, disability, multiple sclerosis, social participation

References (20)

  1. Mikula P, Sc M, Nagyova I, et al. Social participation and health-related quality of life in people with multiple sclerosis. Disabil Health J. 2015;8(1):29–34. http://dx.doi.org/10.1016/j.dhjo.2014.07.002
  2. Hakim AE, Bakheit AMO, Bryant TN, et al. The social impact of multiple sclerosis – a study of 305 patients and their relatives. Disabil Rehabil. 2000;22(6):288–293. http://www.tandfonline.com/doi/full/10.1080/096382800296755
  3. Messmer Uccelli M, Specchia C, Miller D, Battaglia M. Factors that influence the employment status of people with multiple sclerosis: A multi-national study. J Neurol. 2009;256:1989–1996.
  4. Plow MA, Finlayson M, Ont OTR, Gunzler D, Heinemann AW. Correlates of participation in meaningful activities among people with multiple sclerosis. J Rehabil Med. 2015;47:538–545.
  5. Sparling A, Stutts LA, Sanner H, Eijkholt MM. In-person and online social participation and emotional health in individuals with multiple sclerosis. Qual Life Res. 2017;26(11):3089–3097.
  6. Cook JE, Germano AL, Stadler G. An exploratory investigation of social stigma and concealment in patients with multiple sclerosis. Int J MS Care. 2016;18(2):78–84.
  7. Hughes AJ, Hartoonian N, Parmenter B, et al. Cognitive impairment and community integration outcomes in individuals living with multiple sclerosis. Arch Phys Med Rehabil. 2015;96(11):1973–1979. http://dx.doi.org/10.1016/j.apmr.2015.07.003
  8. World Health Organization. International classification of functioning, disability and health. 2001. https://www.who.int/classifications/icf/en/.
  9. Resnik L, Plow MA. Measuring participation as defined by the International Classification of Functioning, Disability and Health: An evaluation of existing measures. Arch Phys Med Rehabil. 2009;90:856–866.
  10. Yorkston KM, Kuehn CM, Johnson KL, Ehde DM, Jensen MP, ­Amtmann D. Measuring participation in people living with multiple sclerosis: A comparison of self-reported frequency, importance and self-efficacy. Disabil Rehabil. 2008;30(2):88–97.
  11. Kwiatkowski A, Marissal J, Pouyfaucon M, Vermersch P, Hautecoeur P, Dervaux B. Social participation in patients with multiple sclerosis: Correlations between disability and economic burden. BMC Neurol. 2014;14:115.
  12. Polman C, Reingold S, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292–302.
  13. World Health Organization. http://www.who.int/classifications/icf/WHODAS2.0_36itemsSELF.pdf. Accessed on December 15, 2017.
  14. Beck AT, Ward CH, Medelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4: 561–571.
  15. Kurtzke J. Rating neurologic impairment in multiple sclerosis: an ex­panded disability status scale (EDSS). Neurology. 1983;33(11):1444–1452.
  16. Garin O, Ayuso-Mateos JL, Almansa J, et al. Validation of the “World Health Organization Disability Assessment Schedule, WHODAS-2” in patients with chronic diseases. Heal Qual Life Outcomes. 2010;8:51.
  17. Cattaneo D, Lamers I, Bertoni R, Feys P, Jonsdottir J. Participation restriction in people with multiple sclerosis: Prevalence and correlations with cognitive, walking, balance, and upper limb impairments. Arch Phys Med Rehabil. 2017;98(7):1308–1315. http://dx.doi.org/10.1016/j.apmr.2017.02.015
  18. Pompeii LA, Moon SD, McCrory DC. Measures of physical and cognitive function and work status among individuals with multiple sclerosis: A review of the literature. J Occup Rehabil. 2005;15(1):69–84.
  19. Yorkston KM, Baylor C, Amtmann D. Journal of Communication Disorders Communicative participation restrictions in multiple sclerosis: Associated variables and correlation with social functioning. J Commun Disord. 2014;52:196–206. http://dx.doi.org/10.1016/j.jcomdis.2014.05.005
  20. Hollingsworth H, Gray DB. Structural equation modeling of the relationships between participation in leisure activities and community environments by people with mobility impairments. Arch Phys Med Rehabil. 2010;91(8):1174–1181. http://dx.doi.org/10.1016/j.apmr.2010.04.019
© Wroclaw Medical University